Transcend CLL 004 Update #ASH19 @cityofhope

Transcend CLL 004 Update #ASH19 @cityofhope

ash

2 months
10 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Chronic Lymphocytic Leukemia
Description:

Tanya Siddiqi, MD of @cityofhope discusses the updated results from transcend CLL 004, a Phase 1/2 study including patients with high-risk disease treated with ibrutinib.

Up Next Autoplay
Servier's R&D Efforts in Oncology #ASH #ASH19
Servier's R&D Efforts in Oncology #ASH #ASH19
Free
144
ash 1 month
Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant #ASH19 @ClevelandClinic
Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant #ASH19 @ClevelandClinic
Free
22
ash 1 month
Are Racial Disparities in AML Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?
Are Racial Disparities in AML Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?
Free
23
ash 1 month
Multiple Myeloma Disparities #ASH19 @WinshipAtEmory
Multiple Myeloma Disparities #ASH19 @WinshipAtEmory
Free
37
ash 1 month
Phase III Lumoxiti #ASH19
Phase III Lumoxiti #ASH19
Free
47
ash 1 month
Comparative Outcomes of Relapsed Follicular Lymphoma Patients #ASH19 @ClevelandClinic
Comparative Outcomes of Relapsed Follicular Lymphoma Patients #ASH19 @ClevelandClinic
Free
39
ash 1 month
Sickle Cell Research #ASH19
Sickle Cell Research #ASH19
Free
8
ash 1 month
CASIRE Study #ASH19
CASIRE Study #ASH19
Free
17
ash 1 month
GRIFFIN Study Update #ASH19 @LevineCancer
GRIFFIN Study Update #ASH19 @LevineCancer
Free
10
ash 2 months
Analysis of Brentuximab Vedotin Plus CHP (A+CHP) #ASH19 @OfficialUoM
Analysis of Brentuximab Vedotin Plus CHP (A+CHP) #ASH19 @OfficialUoM
Free
11
ash 2 months